SCHEMBL536179

SCHEMBL536179

COc1ccccc1-c1ccccc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.62
HPGD P15428 5/20 0.56
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 4/20 0.56
HSD17B10 Q99714 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
CLCN2 P51788 1/20 0.55
MYC P01106 1/20 0.55
KMT2A Q03164 1/20 0.54
MAPK1 P28482 1/20 0.53
ERN1 O75460 1/20 0.52
GPR35 Q9HC97 3/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
ESR1 P03372 1/20 0.52
ITGB3 P05106 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9634001 0.98 HTT (0.61) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL28370924 0.89 MYC (0.61) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL6878826 0.88 KDM4E (0.59) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL4063170 0.86 HTT (0.56) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL27903906 0.86 HTT (0.56) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL13369192 0.85 KDM4E (0.50) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL1957953 0.85 SMN1; SMN2 (0.56) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL29746234 0.84 CLCN2 (0.62) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL14675662 0.84 HTT (0.54) HTTHPGDKDM4EALDH1A1HSD17B10
SCHEMBL17258267 0.84 HTT (0.54) HTTHPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117981493-A Light-emitting element, method for manufacturing light-emitting element, display device, and method for manufacturing display device 夏普显示科技株式会社 2024-05-03 CN claimed
WO-2023079616-A1 LIGHT EMITTING ELEMENT, PRODUCTION METHOD FOR LIGHT EMITTING ELEMENT, DISPLAY DEVICE, AND PRODUCTION METHOD FOR DISPLAY DEVICE シャープディスプレイテクノロジー株式会社 2023-05-11 WO claimed
EP-1427386-B1 PRODUCTS FOR PREVENTING PENETRATION INTO THE SKIN YISSUM RES DEV CO (IL) 2010-10-20 EP claimed
EP-0794789-A4 INHIBITORS OF PRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-05-26 EP claimed
EP-0794789-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-09-17 EP claimed
WO-1996021456-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1996-07-18 WO claimed
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF NANJING ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2025-04-17 US disclosed
EP-4464709-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2024-11-20 EP disclosed
CN-117981493-A Light-emitting element, method for manufacturing light-emitting element, display device, and method for manufacturing display device 夏普显示科技株式会社 2024-05-03 CN disclosed
WO-2023134739-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF 南京再明医药有限公司 2023-07-20 WO disclosed
WO-2023079616-A1 LIGHT EMITTING ELEMENT, PRODUCTION METHOD FOR LIGHT EMITTING ELEMENT, DISPLAY DEVICE, AND PRODUCTION METHOD FOR DISPLAY DEVICE シャープディスプレイテクノロジー株式会社 2023-05-11 WO disclosed
CN-111163753-A Inorganic sunscreen agents with high protection against UV radiation 维佐尔有限责任公司 2020-05-15 CN disclosed
EP-2414328-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Merck Serono S.A. (CH) 2012-02-08 EP disclosed
WO-1994002465-A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF RHONE-POULENC RORER LIMITED (GB) 1994-02-03 WO disclosed
US-4710513-A Substituted pyranone inhibitors of cholesterol synthesis MERCK & CO., INC. (US) 1987-12-01 US disclosed
EP-0239444-A1 Ferroelectric liquid crystal, process for its manufacture and its use in a liquid-crystal mixture THOMSON-CSF (FR) 1987-09-30 EP disclosed
US-4567289-A ANTICHOLESTEROL ANTILIPEMIC MERCK & CO., INC. (US) 1986-01-28 US disclosed
US-4459422-A Substituted pyranone inhibitors of cholesterol synthesis MERCK & CO., INC. (US) 1984-07-10 US disclosed
US-4375475-A ANTICHOLESTEROL AGENTS MERCK & CO., INC. (US) 1983-03-01 US disclosed
EP-0024348-A1 Substituted 6-Phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-R trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them MERCK & CO. INC. (US) 1981-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF POLRMT, POLQ, POLH HTT 97/4885HPGD 1614/4885KDM4E 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.